| Clinicopathological Findings |
| Results |
| Age |
| 28 - 88 (median: 59) |
| Size (mm) |
| 10 - 100 (median: 19) |
| Histology |
|
|
|
| NST1) | 109 (80.6%) |
|
| ILC2) | 13 (9.5%) |
|
| TC3) | 2 (1.5%) |
|
| MUC4) | 9 (6.6%) |
|
| Micropap5) | 1 (0.7%) |
|
| Metaplastic6) | 2 (1.5%) |
|
| Small7) | 1 (0.7%) |
| Grade |
|
|
| nuclear | NG1 | 20 (17.7%) |
|
| NG2 | 88 (77.9%) |
|
| NG3 | 15 (13.3%) |
| histological | HG1 | 42 (37.2%) |
|
| HG2 | 67 (59.3%) |
|
| HG3 | 14 (12.4%) |
| Subtypes |
|
|
|
| Luminal A | 69 (50.4%) |
|
| Luminal B | 50 (36.5%) |
|
| Luminal-HER2 | 6 (4.4%) |
|
| Triple-negative | 9 (6.6%) |
|
| HER2 | 3 (2.2%) |
| Surgical method |
|
|
|
| Total mastectomy | 64 (46.7%) |
|
| Partial mastectomy | 73 (53.3%) |
| Tissue degeneration |
|
|
|
| +8) | 34 (24.8%) |
|
| - | 103 (75.2%) |
| Hot spots |
|
|
|
| + | 56 (40.9%) |
|
| - | 81 (59.1%) |
| number of cores |
| 1-21 (median 2) |
| total length of core needle materials (mm) |
| 7-77 (median 20) |